Article
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 May 2017
Parkhurst Maria, Gros Alena, Pasetto Anna, Prickett Todd, Crystal Jessica S, Robbins Paul, Rosenberg Steven A
Abstract excerpt
Purpose: The adoptive transfer of lymphocytes genetically modified to express tumor reactive T-cell receptors (TCR) can mediate tumor regression. Some tumor-infiltrating lymphocytes (TIL) recognize somatic mutations expressed only in the patient's tumors, and evidence suggests that clinically effective TILs target tumor-specific neoantigens. Here we attempted to isolate neoantigen-reactive TCRs as a prelude to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
